glucagon has been researched along with Chylopericardium in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Crooks, BN; Deshpande, SA; Hall, C; Milligan, DW; Platt, MP | 1 |
1 other study(ies) available for glucagon and Chylopericardium
Article | Year |
---|---|
Adverse neonatal effects of maternal labetalol treatment.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Cardiomegaly; Dobutamine; Dopamine; Drug Therapy, Combination; Fatal Outcome; Female; Glucagon; Humans; Infant, Newborn; Labetalol; Norepinephrine; Pericardial Effusion; Pregnancy; Pregnancy Complications, Cardiovascular; Prenatal Exposure Delayed Effects | 1998 |